<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Leptospirosis: Epidemiology, microbiology, clinical manifestations, and diagnosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Leptospirosis: Epidemiology, microbiology, clinical manifestations, and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Leptospirosis: Epidemiology, microbiology, clinical manifestations, and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nick Day, DM, FRCP</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stephen B Calderwood, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Keri K Hall, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 31, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Leptospirosis is a zoonosis with protean clinical manifestations caused by pathogenic spirochetes of the genus <em>Leptospira</em>. Synonyms for the disease include Weil's disease, Weil-Vasiliev disease, Swineherd's disease, rice-field fever, waterborne fever, nanukayami fever, cane-cutter fever, swamp fever, mud fever, Fort Bragg fever, Stuttgart disease, Mgunda fever, and Canicola fever.</p><p>The epidemiology, microbiology, clinical manifestations, and diagnosis of leptospirosis will be presented here. The treatment and prevention of this disease are discussed separately. (See  <a class="medical medical_review" href="/d/html/5524.html" rel="external">"Leptospirosis: Treatment and prevention"</a>.)</p><p class="headingAnchor" id="H1718316898"><span class="h1">MICROBIOLOGY</span><span class="headingEndMark"> — </span><em>Leptospira</em> are spiral-shaped, highly motile aerobic spirochetes with 18 or more coils per cell.</p><p>The organism stains poorly with common laboratory stains and is best visualized by dark field microscopy, silver stain, or fluorescent microscopy. It can be distinguished morphologically from other spirochetes by its unique "question mark" hook at the end of the bacterium  (<a class="graphic graphic_picture graphicRef90720" href="/d/graphic/90720.html" rel="external">picture 1</a>).</p><p>The phylogeny of <em>Leptospira</em> has undergone a major overhaul since 2018 due to large-scale whole-genome sequencing.</p><p>There are 64 recognized species (60 of these have been published under the rules of the International Code of Nomenclature of Bacteria), split into two clades and four subclades [<a href="#rid1">1,2</a>]. Subclade P1(17 species) contains, alongside newly described species, those species traditionally recognized as pathogenic (<em>Leptospira interrogans</em>, <em>L. kirschneri</em>, <em>L. noguchii</em>, <em>L. alexanderi</em>, <em>L. weilii</em>, <em>L.</em> <em>alstonii</em>, <em>L. borgpetersenii</em>, <em>L. santarosai</em>,<em> L. kmetyi</em>,<em> </em>and<em> L. mayottensis</em>). Subclade P2 contains 20 species, including those species previously regarded as of intermediate or unclear pathogenicity. Subclades S1 and S2 contain 22 and 5 species, respectively, and include those species previously categorized as 'saprophytes.'</p><p>There is an older classification system based on serology, with approximately 300 serovars of pathogenic <em>Leptospira</em> grouped into 32 serogroups; some serovars are found in more than one species of <em>Leptospira</em>. As a result, by convention, isolates are identified by both species and serovar (eg, <em>L. interrogans</em> serovar Copenhageni). Molecular methods have also been developed to classify <em>Leptospira</em> strains beyond the species level [<a href="#rid3">3,4</a>].</p><p>Whole-genome sequencing of strains of the pathogenic species <em>L. interrogans</em> and <em>L. borgpetersenii,</em> and of the saprophytic species <em>L. biflexa,</em> has identified a series of genes possibly related to adhesion, invasion, and hematological findings in hosts [<a href="#rid5">5,6</a>].</p><p class="headingAnchor" id="H3"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H1352987873"><span class="h2">Prevalence and geography</span><span class="headingEndMark"> — </span>Leptospirosis is thought to be the most widespread zoonosis in the world. It is an under-reported infection, and there are no reliable global incidence figures. A systematic review and modeling exercise estimated that more than one million human cases occur worldwide annually, including almost 60,000 deaths [<a href="#rid7">7,8</a>].</p><p>It is most prevalent in tropical regions but also occurs in temperate regions [<a href="#rid7">7,8</a>]. Regions with the highest incidence of infections include South and Southeast Asia, Oceania, the Caribbean, parts of sub-Saharan Africa, and parts of Latin America [<a href="#rid9">9</a>].</p><p>In the United States, the incidence of leptospirosis is relatively low (approximately 100 to 150 cases are reported annually) [<a href="#rid10">10</a>]. Puerto Rico and Hawaii consistently report the most cases.</p><p>Disease in humans is usually sporadic, although outbreaks may occur from common source exposures. (See <a class="local">'Outbreaks'</a> below.)</p><p class="headingAnchor" id="H2511394661"><span class="h2">Animal and environmental reservoirs</span><span class="headingEndMark"> — </span>Mammals act as the primary reservoir for <em>Leptospira </em>organisms. The environment can serve as a reservoir if it becomes contaminated by the urine of infected mammals.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Animal reservoir</strong> – Approximately 160 mammalian species have been identified as natural carriers of pathogenic <em>Leptospira </em>species [<a href="#rid11">11</a>]. The organism lives in the renal tubules of infected mammals and is shed in the urine.</p><p></p><p class="bulletIndent1">Rodents are the most important reservoirs for maintaining transmission in most settings. Infection in small rodents (eg, rats) usually occurs in utero, during birth, or<em> </em>during infancy from environmental contamination of the nest [<a href="#rid12">12</a>]. Once infected, rodents are asymptomatic carriers and shed the organism in their urine intermittently or continuously throughout life, resulting in contamination of the environment, particularly water [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent1">In addition to rodents, the organism infects a variety of both wild and domestic mammals, especially cattle, swine, dogs, horses, sheep, and goats. It rarely occurs in cats. Animals can be asymptomatic carriers or can develop clinical infection, which may be fatal. Mortality in dogs is estimated at approximately 10 percent. Spontaneous abortion is a common outcome of leptospirosis in cattle, swine, sheep, and goats.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Environmental reservoir</strong> – Organisms can survive for days to months in urine-contaminated soil and fresh water [<a href="#rid10">10</a>].</p><p></p><p class="bulletIndent1">Contamination of water with animal urine can occur via several mechanisms:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Following heavy rainfall or flooding that allows mixing of urine-contaminated soil or sewage with water, especially in areas with poor housing and sanitation/sewage conditions that propagate high rodent populations</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Animal excretion of urine into wet soil or bodies of fresh water, such as ponds, lakes, rivers, and streams</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Drainage of urine-contaminated soil or water into bodies of fresh water</p><p></p><p class="headingAnchor" id="H2908550468"><span class="h2">Transmission to humans</span><span class="headingEndMark"> — </span>Humans are accidental hosts, infected incidentally after animal or environmental exposure.</p><p>Transmission of the organism to humans occurs via portals of entry, including cuts or abraded skin, mucous membranes, or conjunctivae [<a href="#rid10">10</a>].</p><p>Human exposures that lead to infection include contact with urine-contaminated soil or water (eg, floodwater, ponds, rivers, streams, sewage), ingestion of food or water contaminated by urine or urine-contaminated water, or direct contact with the urine or reproductive fluids from infected animals [<a href="#rid10">10</a>]. Transmission has also rarely occurred through animal bites. Controversy exists as to whether <em>Leptospira</em> can penetrate intact skin.</p><p>Human-to-human transmission is very rare but has been documented through sexual intercourse and breastfeeding [<a href="#rid10">10</a>].</p><p class="headingAnchor" id="H2057972570"><span class="h2">Risk factors</span><span class="headingEndMark"> — </span>Risk factors primarily include direct animal exposure or activities that can lead to skin abrasions and water or soil exposure [<a href="#rid10">10</a>].</p><p>Specific risk factors for infection include the following [<a href="#rid10">10,13-17</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Occupational exposure – Farmers, ranchers, abattoir workers, trappers, veterinarians, loggers, sewer workers, landscapers, rice farmers, pet traders, military personnel, laboratory workers</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Recreational activities – Freshwater swimming, canoeing, kayaking, trail biking, trekking, gardening</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Household exposure – Pet dogs, domesticated livestock, rainwater catchment systems, infestation by infected rodents</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Low socioeconomic status – Living in overcrowded urban areas with poor sanitation</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Travel to endemic areas (especially if travel occurs during or following heavy rainfall or flooding or involves high-risk activities) (see <a class="local">'Prevalence and geography'</a> above)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other – Walking barefoot through surface water, skin lesions, contact with wild rodents, accidental laboratory exposure</p><p></p><p>In the tropics, endemic leptospirosis is mainly a disease of poverty (including low education, poor housing, absence of sanitation, and poor income) [<a href="#rid18">18,19</a>]. It is usually acquired through occupational exposure (subsistence farming) or living in rodent-infested, flood-prone, overcrowded urban areas [<a href="#rid20">20</a>].</p><p class="headingAnchor" id="H553354261"><span class="h2">Outbreaks</span><span class="headingEndMark"> — </span>Large outbreaks affecting thousands of people and causing tens and hundreds of deaths have been reported [<a href="#rid21">21</a>]. Outbreaks tend to occur after heavy rainfall or flooding in endemic areas, especially in areas with poor housing and sanitation conditions [<a href="#rid10">10,22-26</a>]. In 2022, an outbreak was reported in Tanzania among farmers [<a href="#rid27">27</a>].</p><p>Several outbreaks have been reported around the world in participants in triathlons where the swimming portion was in fresh water [<a href="#rid28">28-31</a>]. A leptospirosis outbreak was also reported among adventure race participants in a swamp in Florida [<a href="#rid32">32</a>]. In 2018, an outbreak in northern Israel was reported and was associated with recreational water exposure [<a href="#rid33">33</a>]. </p><p class="headingAnchor" id="H6"><span class="h1">CLINICAL MANIFESTATIONS</span></p><p class="headingAnchor" id="H596992135"><span class="h2">Spectrum of illness</span><span class="headingEndMark"> — </span>The clinical course of leptospirosis is variable. Most cases are mild and self-limited or asymptomatic, while some are severe and potentially fatal [<a href="#rid34">34</a>].</p><p>Syndromes caused by leptospirosis are often divided into two categories: anicteric leptospirosis and icteric leptospirosis. Icteric leptospirosis is the more severe form of disease and is associated with icterus and jaundice.</p><p class="headingAnchor" id="H2175224478"><span class="h2">Anicteric leptospirosis</span><span class="headingEndMark"> — </span>The majority of symptomatic patients with leptospirosis have the anicteric form of disease.</p><p>Anicteric leptospirosis has been described as a biphasic illness, with an acute phase and an "immune" phase. However, most patients never proceed to the immune phase of illness. In some cases, the two phases may overlap clinically.</p><p class="headingAnchor" id="H2147003055"><span class="h3">Acute phase (first week of illness)</span><span class="headingEndMark"> — </span>The acute phase of anicteric leptospirosis typically lasts two to nine days [<a href="#rid10">10,28,34</a>]. It usually begins 5 to 14 days after exposure, although the incubation period can range from 2 to 30 days.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Symptoms</strong> – The acute phase is characterized by acute febrile bacteremia. Clinical features include abrupt onset of fever, rigors, myalgias (especially in the calves and lower back), and headache; these symptoms occur in 75 to 100 percent of patients [<a href="#rid33">33,35</a>]. Approximately half of patients experience nausea, vomiting, and diarrhea, and nonproductive cough occurs in 25 to 35 percent of cases.</p><p></p><p class="bulletIndent1">Less common symptoms include arthralgias, bone pain, sore throat, and abdominal pain [<a href="#rid36">36</a>]. Acalculous cholecystitis and pancreatitis have been described in children [<a href="#rid37">37</a>].</p><p></p><p class="bulletIndent1">Rarely, rapidly progressive pulmonary hemorrhage can occur during the acute phase, although this finding is more commonly associated with icteric leptospirosis. Symptoms include shortness of breath and hemoptysis. This syndrome is associated a high mortality rate. More details are found elsewhere. (See <a class="local">'Icteric leptospirosis (Weil's disease)'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Physical examination</strong> – In addition to fever, a distinguishing, but often overlooked, finding is conjunctival hyperemia ('suffusion'), which has been reported in a majority of patients with leptospirosis in some case series [<a href="#rid38">38,39</a>]. It is characterized by bilateral dilation of conjunctival blood vessels causing conjunctival erythema without purulent discharge (in contrast to conjunctivitis, which includes purulent discharge) and is uncommon in other infectious diseases. In a minority of patients, subconjunctival hemorrhage (ie, focal, flat, bright red patches) occurs with or without conjunctival suffusion  (<a class="graphic graphic_picture graphicRef96204" href="/d/graphic/96204.html" rel="external">picture 2</a>).</p><p></p><p class="bulletIndent1">In addition to the ophthalmologic findings described above, case series have also reported muscle tenderness, splenomegaly, lymphadenopathy, pharyngitis, hepatomegaly, muscle rigidity, abnormal respiratory auscultation, and/or skin rash in 7 to 40 percent of patients [<a href="#rid34">34,40,41</a>]. If present, the rash typically lasts one to two days and may be maculopapular, urticarial, petechial, or purpuric in nature; pretibial petechiae have been noted, especially from infections caused by the <em>L. autumnalis </em>serotype.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Laboratory findings</strong> – Typical lab findings during the acute phase include neutrophilia, although the total white blood cell (WBC) count can be normal, low, or elevated. Thrombocytopenia and anemia are less common; pancytopenia has been reported as the presenting manifestation in case reports [<a href="#rid42">42</a>]. The erythrocyte sedimentation rate (ESR) is usually elevated, and mild elevation of liver aminotransferases may occur. Elevated creatine kinase (due to rhabdomyolysis) may occur in approximately half of patients [<a href="#rid43">43</a>].</p><p></p><p class="bulletIndent1">Urinalysis frequently shows proteinuria, pyuria, granular casts, and occasionally microscopic hematuria [<a href="#rid41">41</a>]. Rarely, acute kidney injury occurs during this phase, although it is more commonly associated with icteric leptospirosis which is described elsewhere. (See <a class="local">'Icteric leptospirosis (Weil's disease)'</a> below.)</p><p></p><p class="headingAnchor" id="H1532307697"><span class="h3">"Immune" phase (delayed phase of illness)</span><span class="headingEndMark"> — </span>Following the acute phase, a minority of patients with anicteric leptospirosis experience an "immune" phase characterized by specific immune-mediated complications. Rarely, patients can present with the manifestations of the immune phase without experiencing a preceding symptomatic acute phase.</p><p>In those who do develop an immune phase, there is often a period of improvement between the end of the acute phase and the beginning of the immune phase. In others, the acute and immune phases may overlap. The immune phase typically lasts around one week, and no longer than 30 days, except for ophthalmologic complications, as described below.</p><p>During the immune phase, leptospires are absent from the blood, and antibodies to the organism are present. The organism may be detectable in the urine during this phase. Diagnostic testing of various bodily fluids is discussed elsewhere. (See <a class="local">'Diagnosis'</a> below.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Systemic symptoms</strong> – The immune phase usually begins with renewed fever, headache, and myalgia, sometimes accompanied by nausea, vomiting, and abdominal pain [<a href="#rid34">34</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Aseptic meningitis</strong> – Aseptic meningitis is a hallmark of the immune phase, with symptoms of headache and neck pain or stiffness occurring in approximately half of patients [<a href="#rid44">44</a>]. Physical examination findings include nuchal rigidity; papilledema is uncommon. Meningitis symptoms usually subside within one or two days and can rarely persist up to three weeks.</p><p></p><p class="bulletIndent1">Typical cerebrospinal fluid (CSF) findings include neutrophilic or lymphocytic pleocytosis with mildly elevated protein and normal glucose; these findings are found in 50 to 85 percent of patients whose CSF is examined during the immune phase, including in patients without meningitis symptoms. Rarely, a low glucose concentration is present [<a href="#rid45">45</a>]. CSF pleocytosis may persist for up to three months [<a href="#rid44">44</a>].<br/></p><p class="bulletIndent1">In general, CSF abnormalities and meningitis symptoms have been attributed to the host immune response to the organism rather than to infection of the central nervous system [<a href="#rid41">41</a>]. However, in one study that included 15 patients with serologically confirmed leptospirosis and lymphocytic aseptic meningitis in Brazil, 14 (93 percent) had detectable <em>Leptospira</em> DNA in the CSF by polymerase chain reaction (PCR) [<a href="#rid46">46</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Uveitis</strong> – Unilateral or bilateral uveitis is another feature of the immune phase and may be recurrent. The most common presentation is anterior uveitis (ie, iritis, iridocyclitis), which manifests as acute-onset or insidious pain and redness of the eye(s), primarily at the limbus (the junction between the cornea and the sclera). Less commonly, posterior uveitis (eg, chorioretinitis) occurs and presents as painless visual changes (eg, floaters, decreased visual acuity) in one or both normal-appearing eyes. Both types of uveitis typically have a good prognosis and can be diagnosed by examination by an ophthalmologist [<a href="#rid47">47</a>]. More details regarding uveitis are found elsewhere. (See  <a class="medical medical_review" href="/d/html/5581.html" rel="external">"Uveitis: Etiology, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H1255005446"><span class="h2">Icteric leptospirosis (Weil's disease)</span><span class="headingEndMark"> — </span>Icteric leptospirosis occurs in approximately 5 to 10 percent of symptomatic leptospirosis cases and is a rapidly progressive multisystem illness associated with mortality rates of 5 to 15 percent [<a href="#rid34">34</a>].</p><p>Usually, icteric leptospirosis is accompanied by fever, jaundice, and renal failure, a syndrome known as "Weil's disease." Pulmonary hemorrhage with acute respiratory distress syndrome (ARDS), myocarditis with electrocardiogram (EKG) abnormalities, and rhabdomyolysis may also occur as part of this syndrome [<a href="#rid34">34,47-52</a>]. Conjunctival suffusion is also common  (<a class="graphic graphic_picture graphicRef96204" href="/d/graphic/96204.html" rel="external">picture 2</a>).</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hepatic findings</strong> – Physical examination reveals scleral icterus and jaundice, and conjugated bilirubin is elevated with normal or slightly elevated aminotransferases. In some cases, the serum bilirubin concentration reaches 60 to 80 mg/dL (1026 to 1368 mmol/L). Liver failure is rare, and liver enzymes and bilirubin abnormalities typically resolve without permanent liver damage.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Renal findings</strong> – Renal failure may be oliguric or nonoliguric. The serum creatinine is often markedly elevated, and serum potassium abnormalities and hyponatremia are common [<a href="#rid53">53,54</a>]. Supportive renal replacement therapy (eg, hemodialysis) may be required for survival in up to half of patients with Weil’s disease, but complete renal recovery is typical after discontinuation of renal replacement therapy [<a href="#rid55">55</a>]. Although this manifestation is most commonly associated with icteric disease (Weil’s disease), some more recent reports suggest that acute kidney failure can sometimes occur in the absence of icterus and jaundice [<a href="#rid51">51</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pulmonary findings</strong> – Severe pulmonary disease, characterized by pulmonary hemorrhage, is a serious complication of Weil's disease. This manifestation is seen in less than 5 percent of patients and has been reported to be fatal in 50 to 70 percent of patients [<a href="#rid56">56</a>]. Symptoms include shortness of breath, cough, and hemoptysis. Laboratory findings associated with pulmonary hemorrhage include thrombocytopenia, anemia, and results compatible with disseminated intravascular coagulation (DIC; elevated coagulation tests and D-dimer with low fibrinogen) [<a href="#rid57">57</a>]. Imaging typically reveals bilateral patchy peripheral infiltrates, often with a "snowflake" appearance, that can progress to confluent consolidation or a ground-glass appearance. Pathologically, these infiltrates may represent alveolar hemorrhage, ARDS, or pulmonary edema [<a href="#rid58">58</a>]. Death typically occurs within a few days of onset. This syndrome may be underdiagnosed in highly endemic regions and has sometimes been associated with nonicteric acute leptospirosis in recent reports [<a href="#rid52">52,59</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cardiovascular findings</strong> – Cardiovascular abnormalities, including myocarditis with heart failure or cardiogenic shock, have been reported. EKG abnormalities have been reported in over half of patients with severe leptospirosis, with nonspecific ventricular repolarization disturbances being the most common finding [<a href="#rid60">60</a>]. Vasculitis with necrosis of extremities may also be seen in severe cases, including in children [<a href="#rid52">52,61</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other findings</strong> – Other findings associated with icteric leptospirosis include neutrophilia (although the total WBC count can be normal, low, or elevated) and elevated creatine kinase consistent with rhabdomyolysis.</p><p></p><p class="headingAnchor" id="H1481660402"><span class="h2">Special populations</span></p><p class="headingAnchor" id="H1455593024"><span class="h3">Pregnant patients</span><span class="headingEndMark"> — </span>Leptospirosis in pregnancy may be misdiagnosed as it can mimic other pregnancy-associated conditions, including other infections, pregnancy-associated hypertension, acute fatty liver, and HELLP (hemolysis, elevated liver enzymes, and low platelet count syndrome) [<a href="#rid62">62</a>]. Transplacental infection occurs, but the rate of fetal transmission and the type and frequency of fetal complications are unknown [<a href="#rid62">62-64</a>]. In one review of 14 pregnancies with active maternal infection, there were eight spontaneous abortions, four infants with active infection, and two healthy neonates [<a href="#rid63">63</a>]. Another series of 11 cases noted risk of abortion or fetal death of over 50 percent [<a href="#rid64">64</a>]. Information on sequelae in surviving neonates is sparse.</p><p class="headingAnchor" id="H1175762981"><span class="h3">Immunocompromised patients</span><span class="headingEndMark"> — </span>Limited data suggest that the clinical course and outcomes of leptospirosis in immunocompromised individuals is similar to that of immunocompetent individuals [<a href="#rid65">65-67</a>]. Among patients with solid organ transplants, a review of case reports of leptospirosis concluded that occurrence of leptospirosis was more likely related to epidemiologic exposure than to increased risk of infection in the setting of immunosuppression [<a href="#rid68">68</a>].</p><p class="headingAnchor" id="H11"><span class="h1">DIAGNOSIS</span></p><p class="headingAnchor" id="H6606693"><span class="h2">Clinical suspicion</span><span class="headingEndMark"> — </span>The level of suspicion for leptospirosis in a given patient depends primarily on the clinical syndrome and the local epidemiology of the infection.</p><p>Leptospirosis should be suspected in patients who have a compatible systemic febrile illness and no clear alternative explanation, especially if they have exposures to endemic or outbreak settings or have engaged in high-risk activities. In nonendemic areas, a high index of suspicion is necessary to make the diagnosis. A thorough history should be sought to assess for risk factors, including occupational hazards, exposures to bodies of fresh water, recent travel to endemic or flooded areas, or exposures to rats. The geographic prevalence and risk factors for infection are discussed in detail elsewhere. (See <a class="local">'Epidemiology'</a> above.)</p><p>Compatible syndromes include nonspecific febrile illness (especially if accompanied by conjunctival hyperemia or suffusion and calf myalgias), aseptic meningitis or uveitis (especially if preceded by a febrile illness), unexplained jaundice and acute kidney injury with fever, or unexplained pulmonary hemorrhage. The absence of conjunctival hyperemia or suffusion does not rule out the possibility of leptospirosis. In pregnant women, leptospirosis should be considered if similar syndromes occur along with spontaneous abortion or unexplained infection of the infant. Clinical manifestations are discussed in detail elsewhere. (See <a class="local">'Clinical manifestations'</a> above.)</p><p>In the setting of moderate or high clinical suspicion for leptospirosis in the absence of a definitive laboratory diagnosis, administration of empiric treatment is appropriate. (See  <a class="medical medical_review" href="/d/html/5524.html" rel="external">"Leptospirosis: Treatment and prevention"</a>.)</p><p class="headingAnchor" id="H6606699"><span class="h2">Confirming the diagnosis</span><span class="headingEndMark"> — </span>A definitive diagnosis is made by laboratory-based tests.</p><p class="headingAnchor" id="H3998977896"><span class="h3">Approach to testing</span><span class="headingEndMark"> — </span>When leptospirosis is suspected, we notify the microbiology laboratory prior to sending samples, so they can use specialized techniques. We send the following lab tests:</p><p class="bulletIndent1"><span class="glyph">●</span>Blood samples for polymerase chain reaction (PCR) and serology (immunoglobulin [Ig]M and IgG). We also send leptospire culture if available. We order follow-up serology 7 to 14 days after the initial serologic test.</p><p class="bulletIndent1"><span class="glyph">●</span>Urine samples for PCR (and leptospire culture if available). These are particularly valuable beyond one week after the onset of symptoms.</p><p class="bulletIndent1"><span class="glyph">●</span>Cerebrospinal fluid (CSF) for PCR (for patients with meningitis).</p><p></p><p>The diagnosis is confirmed by a positive PCR of blood or urine or by positive serologic testing; rarely, a diagnosis is made by a positive culture of blood or urine. The diagnosis is not ruled out by negative test results, because the sensitivity of leptospirosis testing is suboptimal.</p><p>Nucleic acid detection (eg, PCR) is most sensitive during the bacteremic phase (ie, the first week) of infection, with antibodies becoming detectable by serology after the first week. Hence, for timely diagnosis of patients with suspected leptospirosis, a combined serologic/molecular diagnostic approach is increasingly used [<a href="#rid69">69,70</a>]. The exact combination of tests used depends on local availability.</p><p>Details regarding each type of testing is found elsewhere. (See <a class="local">'Molecular tests (eg, PCR)'</a> below and <a class="local">'Serology'</a> below and <a class="local">'Other tests'</a> below.)</p><p class="headingAnchor" id="H747075543"><span class="h3">Molecular tests (eg, PCR)</span><span class="headingEndMark"> — </span>Molecular tests, such as PCR, can provide rapid, accurate diagnosis of leptospirosis, especially early in the course of illness (ie, the acute phase) [<a href="#rid71">71</a>]. The tests are available commercially and from some public health laboratories, including the Centers for Disease Control and Prevention (CDC) in the United States.</p><p>A single positive PCR is confirmatory of leptospirosis infection. However, the sensitivity of PCR testing depends on the timing of collection of the sample relative to the onset of symptoms. Due to the transience of leptospires in bodily fluids, a negative PCR does not rule out leptospirosis.</p><p>PCR tests can be performed on multiple types of samples [<a href="#rid10">10</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Blood – During the first four to six days of symptoms, leptospires are often detected by PCR in the blood.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Urine – The organism may be intermittently identified by PCR in the urine during the first week of illness but is more reliably present after one week of illness.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>CSF – In patients with meningitis, PCR is often negative in the CSF, presumably because most cases of meningitis are due to immune-mediated mechanisms as opposed to ongoing active infection. CSF findings are discussed in detail above. (See <a class="local">'"Immune" phase (delayed phase of illness)'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tissue – Although biopsy is rarely performed, PCR can be performed on tissue. From deceased patients, CDC suggests PCR testing of fresh frozen kidney (preferred) or liver samples.</p><p></p><p>The overall sensitivity of PCR tests in studies typically ranges from 40 to 60 percent in blood samples, and the specificity is above 95 percent [<a href="#rid71">71-74</a>]. In a meta-analysis of 11 studies categorized as having low risk of bias, conventional PCR performed on blood, urine, or both had a pooled sensitivity of 87 percent (95% CI, 44-98) and specificity of 97 percent (95% CI, 60-100) [<a href="#rid71">71</a>]. For real-time PCR, meta-analysis of 10 studies at low risk of bias revealed a median specificity of 92 percent, with significantly lower sensitivity (eg, sensitivity was only 40 percent when specificity was fixed at 90 percent on a receiver operating characteristic [ROC] curve). One of the main variables lending uncertainty in the included studies was lack of control for the timing of the testing relative to onset of symptoms.</p><p>Some molecular tests, such as real-time PCR and loop-mediated isothermal amplification, have the potential to be used as point-of-care tests in resource-limited settings because they don't require sophisticated microbiology laboratories and equipment. Sensitivity and specificity of such rapid tests has varied between studies [<a href="#rid71">71,75-80</a>].</p><p class="headingAnchor" id="H13"><span class="h3">Serology</span><span class="headingEndMark"> — </span>Serologic tests measure specific immunoglobulin (Ig)M and IgG antibodies against <em>Leptospira</em> organisms [<a href="#rid81">81</a>].</p><p>To diagnose leptospirosis by serologic testing, one blood sample should be obtained upon presentation (ie, an acute sample) and a second sample should be obtained 7 to 14 days after the first antibody test is sent (ie, a convalescent sample). A four-fold change in IgG titer confirms infection.</p><p>If only one blood sample can be sent for serologic testing, a sample collected during the first 7 to 10 days of illness is preferred. A single IgG titer that is very high (eg, &gt;1:800 on a microscopic agglutination test [MAT] test) is reasonable evidence of infection, although a single positive or negative IgM or IgG test cannot confirm or rule out infection.</p><p>Like PCR tests, serologic tests can be negative despite active or recent infection, particularly in specific situations:</p><p class="bulletIndent1"><span class="glyph">●</span>Antibodies to leptospirosis develop 3 to 10 days after onset of symptoms and may not reach detectable levels within the first week. Patients with negative initial serology can be confirmed to have infection if a subsequent convalescent sample shows a significant conversion from undetectable to a positive titer, as described above.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Antibody tests that do not detect all serovars of <em>Leptospira </em>may produce negative results in the setting of true infection [<a href="#rid82">82,83</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In theory, antibiotic treatment may abort IgM and IgG production, which may prevent four-fold rises in convalescent titers, although this has not been specifically documented in studies.</p><p></p><p>Unlike PCR, serologic tests can be positive in the absence of ongoing infection, particularly in specific situations:</p><p class="bulletIndent1"><span class="glyph">●</span>Patients with past leptospirosis can have persistently positive IgG results, sometimes persisting for many years. As described above, correct timing of acute and convalescent titers can differentiate past from acute infection.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Like IgG, a single positive IgM antibody titer should not be used to make a definitive diagnosis of acute or recent infection. IgM antibody tests are frequently offered by commercial labs, but many have been inadequately validated and their diagnostic performance is uncertain [<a href="#rid84">84-86</a>]. A positive IgM test can be suggestive of infection in the appropriate clinical setting and should prompt further confirmatory testing [<a href="#rid10">10</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In some situations, antibody tests can be positive due to cross-reactivity with other organisms (eg, syphilis). There are no definitive data that this occurs with leptospirosis antibody testing.</p><p></p><p>Serologic tests are available from multiple commercial laboratories and the United States CDC. Laboratories use different methodologies to perform serologic tests:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microscopic agglutination test (MAT)</strong> – The MAT is the historical reference standard for leptospirosis. The test requires live organisms, considerable expertise, and is performed only by reference laboratories, such as the CDC.</p><p></p><p class="bulletIndent1">Despite its historical role as the reference standard, studies have suggested that MAT serologic testing may not be as sensitive as other diagnostic techniques and testing algorithms [<a href="#rid74">74,82,83,87</a>]. For instance, a meta-analysis of four studies involving over 1600 patients with suspected leptospirosis found a sensitivity for MAT of 50 percent (95% CI, 38-61) and a specificity of 99 percent (95% CI, 93-100); in this meta-analysis, the sensitivity of other types of serologic testing was higher and specificity was comparable [<a href="#rid74">74</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other serologic tests</strong> – Serologic tests other than the MAT are widely available in commercial laboratories. Such tests include enzyme-linked immunosorbent assay (ELISA), immunofluorescence assay (IFA), lateral flow tests, and indirect hemagglutination tests [<a href="#rid88">88,89</a>].</p><p></p><p class="bulletIndent1">Some serologic tests, such as the lateral flow assay, offer point-of-care testing. In a meta-analysis that compared a commonly used lateral flow assay with the MAT, the lateral flow assay had a pooled sensitivity and specificity of 75 percent (95% CI, 64-84) and 87 percent (95% CI, 77-94) respectively [<a href="#rid90">90,91</a>].</p><p></p><p class="headingAnchor" id="H6606566"><span class="h3">Other tests</span><span class="headingEndMark"> — </span>Other tests that are used less frequently can be used to make a diagnosis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Culture</strong> – Although leptospirosis can be confirmed by culture of blood, urine, or CSF, the sensitivity of culture is suboptimal. Isolation of the organism is successful in 5 to 50 percent of cases and may take several weeks [<a href="#rid74">74,92</a>].</p><p></p><p class="bulletIndent1">Blood and CSF specimens may be positive during the first 10 days of the illness. Urine cultures may become positive during the second week of the illness and remain positive for up to 30 days after the resolution of symptoms [<a href="#rid36">36</a>].</p><p></p><p class="bulletIndent1">The laboratory needs to be notified prior to attempting to culture leptospires. Special media are required for isolation such as Fletcher's, Ellinghausen-McCullough-Johnson-Harris, or polysorbate-80 media. Growth is usually observed in one to two weeks but may take up to three months. A method of growing leptospires on solid agar has been developed to facilitate more rapid growth, identification of single colonies, and antimicrobial sensitivity testing [<a href="#rid93">93</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Antigen detection</strong> – Antigen detection in blood using a monoclonal anti-<em>LipL32</em> antibody-based antigen capture ELISA has been developed and validated against PCR [<a href="#rid94">94</a>]. This test is not widely available but may provide a cost-effective alternative to PCR for diagnosis of early infection.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Blood smears</strong> – Darkfield microscopic examination of a peripheral blood smear may sometimes reveal spirochetes during the first few days of infection. However, this test is hampered by low sensitivity and specificity, and it requires technical expertise and specialized laboratory equipment [<a href="#rid95">95</a>]. It is no longer recommended for routine diagnosis. The number of organisms in the blood must be substantial to visualize the organism: 104 leptospires/mL is necessary for one organism/field to be visible.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Histopathology</strong> – Biopsies are rarely performed in patients suspected of leptospirosis infection. On formalin-fixed biopsied tissue, immunohistochemistry tests can confirm the diagnosis, including in deceased patients [<a href="#rid10">10</a>]. Acceptable tissues are kidney (preferred), liver, lung, heart, or spleen.</p><p></p><p class="headingAnchor" id="H2422521329"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>Leptospirosis may be difficult to distinguish from many other infectious illnesses and some noninfectious diseases. Conjunctival suffusion, when it occurs, is one of the most reliable distinguishing features since it rarely occurs with other infectious illnesses.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Infectious etiologies</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Infections that also have conjunctival suffusion</strong> – These include measles, rubella, adenovirus, hantavirus, toxic shock syndrome, and Rocky Mountain spotted fever [<a href="#rid96">96-98</a>]. They each have distinguishing features (eg, rash) that may help differentiate them from leptospirosis. (See  <a class="medical medical_review" href="/d/html/3021.html" rel="external">"Measles: Clinical manifestations, diagnosis, treatment, and prevention", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/d/html/8301.html" rel="external">"Rubella", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/d/html/8339.html" rel="external">"Pathogenesis, epidemiology, and clinical manifestations of adenovirus infection", section on 'Clinical presentation'</a> and  <a class="medical medical_review" href="/d/html/8321.html" rel="external">"Hantavirus cardiopulmonary syndrome", section on 'Clinical features'</a> and  <a class="medical medical_review" href="/d/html/3161.html" rel="external">"Staphylococcal toxic shock syndrome", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/d/html/7904.html" rel="external">"Clinical manifestations and diagnosis of Rocky Mountain spotted fever", section on 'Clinical manifestations'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Severe sepsis and septic shock from common bacterial syndromes</strong> – Common infections such as bacterial pneumonia and bacteremia can cause multiorgan-system failure and sometimes are associated with jaundice. Blood and urine cultures, imaging, and other diagnostic tests can help to detect these infections. (See  <a class="medical medical_review" href="/d/html/1657.html" rel="external">"Sepsis syndromes in adults: Epidemiology, definitions, clinical presentation, diagnosis, and prognosis", section on 'Clinical presentation'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Infections that are common in areas where leptospirosis is endemic</strong></p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Malaria – This infection can present with mild nonspecific febrile illness or multiorgan-system involvement, including jaundice. In areas where malaria is endemic, it should be ruled out by blood smear or polymerase chain reaction (PCR). (See  <a class="medical medical_review" href="/d/html/5709.html" rel="external">"Malaria: Clinical manifestations and diagnosis in nonpregnant adults and children"</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Dengue and chikungunya [<a href="#rid99">99</a>] – Dengue can be difficult to distinguish from leptospirosis because both are febrile illnesses that can range from mild disease to severe illness with hemorrhage and eye findings. Chikungunya is a typically mild, nonspecific febrile illness, although in some cases it can present with diffuse arthritis. Jaundice is uncommon in both infections. (See  <a class="medical medical_review" href="/d/html/3025.html" rel="external">"Dengue virus infection: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/3024.html" rel="external">"Chikungunya fever: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Scrub typhus presents similarly to the acute phase of leptospirosis. A distinguishing feature is rash (often including the face), eschar at the site of a chigger bite, and regional lymphadenopathy. (See  <a class="medical medical_review" href="/d/html/7911.html" rel="external">"Scrub typhus", section on 'Clinical manifestations'</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Other rickettsial disease, including <em>Rickettsia typhi</em> (murine typhus) or spotted fever group rickettsiae, may present with a broad range of infectious symptoms. Murine typhus may have ocular hemorrhage as well as rash. (See  <a class="medical medical_review" href="/d/html/7906.html" rel="external">"Murine typhus"</a> and  <a class="medical medical_review" href="/d/html/7908.html" rel="external">"Other spotted fever group rickettsial infections"</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Typhoid and paratyphoid fever can mimic leptospirosis, particularly in patients with prominent gastrointestinal complaints. (See  <a class="medical medical_review" href="/d/html/2708.html" rel="external">"Enteric (typhoid and paratyphoid) fever: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Hantavirus and other hemorrhagic fevers can present with renal, pulmonary, and ophthalmologic complications similar to those observed in leptospirosis. Like leptospirosis, rodents are important reservoirs for hantavirus. (See  <a class="medical medical_review" href="/d/html/7240.html" rel="external">"Kidney involvement in hantavirus infections"</a> and  <a class="medical medical_review" href="/d/html/8321.html" rel="external">"Hantavirus cardiopulmonary syndrome"</a> and  <a class="medical medical_review" href="/d/html/103771.html" rel="external">"Lassa fever", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/d/html/3022.html" rel="external">"Clinical manifestations and diagnosis of Ebola virus disease", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/d/html/3032.html" rel="external">"Yellow fever: Epidemiology, clinical manifestations, and diagnosis", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/d/html/102363.html" rel="external">"Crimean-Congo hemorrhagic fever", section on 'Clinical manifestations'</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Acute viral hepatitis, especially hepatitis A, can present with fever and jaundice. Renal and pulmonary involvement are uncommon. (See  <a class="medical medical_review" href="/d/html/2692.html" rel="external">"Hepatitis A virus infection in adults: Epidemiology, clinical manifestations, and diagnosis", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/d/html/3627.html" rel="external">"Hepatitis B virus: Clinical manifestations and natural history", section on 'Acute hepatitis'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Other infectious etiologies</strong></p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Tickborne infections</strong> – In addition to rickettsial infections, Ehrlichiosis, <em>Anaplasma</em>, and Babesia can present with nonspecific febrile syndromes. Renal involvement is uncommon but can occur in severe cases. Pulmonary involvement is rare. Jaundice may be present in babesiosis. (See  <a class="medical medical_review" href="/d/html/7907.html" rel="external">"Human ehrlichiosis and anaplasmosis"</a> and  <a class="medical medical_review" href="/d/html/5670.html" rel="external">"Babesiosis: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Acute viral illnesses</strong> – Common viral infections, including influenza, can mimic the acute phase of leptospirosis, particularly in patients with prominent respiratory tract symptoms. Kidney injury, jaundice, and pulmonary hemorrhage are uncommon. (See  <a class="medical medical_review" href="/d/html/7004.html" rel="external">"Seasonal influenza in adults: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Noninfectious etiologies</strong> – Several noninfectious syndromes can be associated with fever and a combination of either kidney, liver, or pulmonary manifestations, including the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome (TTP/HUS) – These syndromes are associated with fever, thrombocytopenia, acute kidney injury, and jaundice. (See  <a class="medical medical_review" href="/d/html/88648.html" rel="external">"Diagnostic approach to suspected TTP, HUS, or other thrombotic microangiopathy (TMA)"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Vasculitic pulmonary-renal syndromes – Autoimmune vasculitic syndromes may be associated with fever, pulmonary hemorrhage, and acute kidney injury. Such syndromes include ANCA-associated vasculitis, anti-glomerular basement membrane disease, and systemic lupus erythematosus. (See  <a class="medical medical_review" href="/d/html/4668.html" rel="external">"Clinical manifestations and diagnosis of systemic lupus erythematosus in adults", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/d/html/3060.html" rel="external">"Clinical spectrum of antineutrophil cytoplasmic autoantibodies"</a> and  <a class="medical medical_review" href="/d/html/3108.html" rel="external">"Anti-GBM (Goodpasture) disease: Pathogenesis, clinical manifestations, and diagnosis", section on 'Clinical manifestations'</a>.)</p><p></p><p class="headingAnchor" id="H2858183"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/83289.html" rel="external">"Patient education: Leptospirosis (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H15"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microbiology</strong> – <em>Leptospira</em> are spiral-shaped, highly motile aerobic spirochetes with 18 or more coils per cell. (See <a class="local">'Microbiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – Leptospirosis is a worldwide zoonotic infection but is most prevalent in tropical regions. Disease in humans is usually sporadic, although outbreaks may occur from common source exposures. (See <a class="local">'Prevalence and geography'</a> above and <a class="local">'Outbreaks'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Transmission to humans</strong> – Mammals (especially rodents) act as the primary reservoir for <em>Leptospira</em>, and they shed the organism in their urine into the environment. Humans become infected via contact with urine-contaminated soil or freshwater through cuts or abraded skin, mucous membranes, or conjunctivae. (See <a class="local">'Animal and environmental reservoirs'</a> above and <a class="local">'Transmission to humans'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors</strong> – Numerous risk factors have been identified, including occupation (eg, farming, sewer work, military), recreational activity (eg, freshwater swimming, kayaking, gardening), household (eg, pet dogs, infestation by rodents), travel to endemic areas, and living in overcrowded urban areas with poor sanitation. (See <a class="local">'Risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – Most cases are mild or asymptomatic, although some are severe and potentially fatal. Two distinct syndromes have been identified:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Anicteric leptospirosis</strong> – The majority of symptomatic patients have this form of disease. It is generally described as a biphasic illness, although most only experience the acute phase. (See <a class="local">'Anicteric leptospirosis'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Acute phase</strong> – This phase typically lasts about one week and is a nonspecific febrile illness characterized by abrupt onset of fever, rigors, myalgias (especially in the calves and lower back), and headache. A distinguishing feature is conjunctival suffusion, which occurs in over half of patients. (See <a class="local">'Acute phase (first week of illness)'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>"Immune" phase</strong> – A minority of patients experience this phase, which is characterized by return of fever, headache, and myalgia that last about one week. Aseptic meningitis and uveitis can complicate this phase. (See <a class="local">'"Immune" phase (delayed phase of illness)'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Icteric leptospirosis (Weil's disease)</strong> – This rapidly progressive multisystem illness occurs in 5 to 10 percent of patients and has a mortality rate of 5 to 15 percent. Features include fever, jaundice, and renal failure. Pulmonary hemorrhage is a severe complication that has been reported to be fatal in 50 to 70 percent of affected patients. (See <a class="local">'Icteric leptospirosis (Weil's disease)'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – Leptospirosis should be suspected in patients who have a compatible febrile illness with no clear alternative explanation, especially in endemic areas or outbreak settings. A high index of suspicion is necessary to make the diagnosis, and a thorough history should be performed to assess for risk factors. (See <a class="local">'Clinical suspicion'</a> above.)</p><p></p><p class="bulletIndent1">The diagnosis is confirmed by a positive polymerase chain reaction (PCR) of blood or urine or by positive serologic testing; rarely, a diagnosis is made by a positive culture of blood or urine. The diagnosis is not ruled out by negative test results because the sensitivity of leptospirosis testing is suboptimal.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Diagnostic evaluation</strong> – When leptospirosis is suspected, we send the following lab tests (see <a class="local">'Confirming the diagnosis'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Blood samples for PCR, serology (IgM and IgG), and culture, if available. We also send follow-up serology 7 to 14 days after the initial serologic test.</p><p class="bulletIndent3"><span class="glyph">-</span>Urine samples for PCR and culture, if available.</p><p class="bulletIndent3"><span class="glyph">-</span>CSF for PCR (for patients with meningitis).</p><p></p><p class="bulletIndent2">We notify the microbiology laboratory prior to sending cultures so they can use specialized techniques to culture the organism, if available.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – The differential diagnosis is broad and depends on the geographic location. In endemic areas, malaria, dengue, typhus, typhoid fever, hepatitis A, and hemorrhagic fevers should be considered, among numerous other infections.</p><p></p><p class="bulletIndent1">Severe sepsis and septic shock from bacterial infections can mimic leptospirosis, especially in patients suspected of having icteric leptospirosis (Weil’s disease).</p><p></p><p class="bulletIndent1">Noninfectious mimickers include thrombotic thrombocytopenic purpura (TTP) and vasculitic pulmonary-renal syndromes. (See <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="headingAnchor" id="H18475049"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Dr. E Dale Everett, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Vincent AT, Schiettekatte O, Goarant C, et al. Revisiting the taxonomy and evolution of pathogenicity of the genus Leptospira through the prism of genomics. PLoS Negl Trop Dis 2019; 13:e0007270.</a></li><li><a class="nounderline abstract_t">Casanovas-Massana A, Vincent AT, Bourhy P, et al. Leptospira dzianensis and Leptospira putramalaysiae are later heterotypic synonyms of Leptospira yasudae and Leptospira stimsonii. Int J Syst Evol Microbiol 2019; 71.</a></li><li><a class="nounderline abstract_t">Boonsilp S, Thaipadungpanit J, Amornchai P, et al. A single multilocus sequence typing (MLST) scheme for seven pathogenic Leptospira species. PLoS Negl Trop Dis 2013; 7:e1954.</a></li><li><a class="nounderline abstract_t">Slack AT, Dohnt MF, Symonds ML, Smythe LD. Development of a Multiple-Locus Variable Number of Tandem Repeat Analysis (MLVA) for Leptospira interrogans and its application to Leptospira interrogans serovar Australis isolates from Far North Queensland, Australia. Ann Clin Microbiol Antimicrob 2005; 4:10.</a></li><li><a class="nounderline abstract_t">Ren SX, Fu G, Jiang XG, et al. Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing. Nature 2003; 422:888.</a></li><li><a class="nounderline abstract_t">Ko AI, Goarant C, Picardeau M. Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen. Nat Rev Microbiol 2009; 7:736.</a></li><li><a class="nounderline abstract_t">Costa F, Hagan JE, Calcagno J, et al. Global Morbidity and Mortality of Leptospirosis: A Systematic Review. PLoS Negl Trop Dis 2015; 9:e0003898.</a></li><li><a class="nounderline abstract_t">Torgerson PR, Hagan JE, Costa F, et al. Global Burden of Leptospirosis: Estimated in Terms of Disability Adjusted Life Years. PLoS Negl Trop Dis 2015; 9:e0004122.</a></li><li class="breakAll">Galloway RL, Schafer R, Stoddard RA. Centers for Disease Control and Prevention. Yellow Book, Chapter 4: Travel-related infections, section on Leptospirosis. https://wwwnc.cdc.gov/travel/yellowbook/2020/travel-related-infectious-diseases/leptospirosis (Accessed on August 30, 2022).</li><li class="breakAll">Centers for Disease Control and Prevention. Leptospirosis: Fact sheet for clinicians. https://www.cdc.gov/leptospirosis/pdf/fs-leptospirosis-clinicians-eng-508.pdf (Accessed on August 18, 2022).</li><li class="breakAll">European Centre for Disease Prevention and Control. Factsheet about leptospirosis. https://www.ecdc.europa.eu/en/leptospirosis/factsheet#:~:text=Leptospirosis%20is%20the%20most%20widespread,Mediterranean%20and%20East%20European%20regions. (Accessed on August 20, 2022).</li><li class="breakAll">Minter A, Federico C, Hussein K, et al. Optimal control of rat-borne leptospirosis in an urban environment. Frontiers in Ecology and Evolution 2019. https://www.frontiersin.org/articles/10.3389/fevo.2019.00209/full (Accessed on August 20, 2022).</li><li><a class="nounderline abstract_t">Nardone A, Capek I, Baranton G, et al. Risk factors for leptospirosis in metropolitan France: results of a national case-control study, 1999-2000. Clin Infect Dis 2004; 39:751.</a></li><li><a class="nounderline abstract_t">Sugunan AP, Natarajaseenivasan K, Vijayachari P, Sehgal SC. Percutaneous exposure resulting in laboratory-acquired leptospirosis -- a case report. J Med Microbiol 2004; 53:1259.</a></li><li><a class="nounderline abstract_t">Wasiński B, Dutkiewicz J. Leptospirosis--current risk factors connected with human activity and the environment. Ann Agric Environ Med 2013; 20:239.</a></li><li><a class="nounderline abstract_t">Sugunan AP, Vijayachari P, Sharma S, et al. Risk factors associated with leptospirosis during an outbreak in Middle Andaman, India. Indian J Med Res 2009; 130:67.</a></li><li><a class="nounderline abstract_t">Lupi O, Netto MA, Avelar K, et al. Cluster of leptospirosis cases among military personnel in Rio de Janeiro, Brazil. Int J Infect Dis 2013; 17:e129.</a></li><li><a class="nounderline abstract_t">Jesus MS, Silva LA, Lima KM, Fernandes OC. Cases distribution of leptospirosis in City of Manaus, State of Amazonas, Brazil, 2000-2010. Rev Soc Bras Med Trop 2012; 45:713.</a></li><li><a class="nounderline abstract_t">Khalil H, Santana R, de Oliveira D, et al. Poverty, sanitation, and Leptospira transmission pathways in residents from four Brazilian slums. PLoS Negl Trop Dis 2021; 15:e0009256.</a></li><li><a class="nounderline abstract_t">Reis RB, Ribeiro GS, Felzemburgh RD, et al. Impact of environment and social gradient on Leptospira infection in urban slums. PLoS Negl Trop Dis 2008; 2:e228.</a></li><li><a class="nounderline abstract_t">Munoz-Zanzi C, Groene E, Morawski BM, et al. A systematic literature review of leptospirosis outbreaks worldwide, 1970-2012. Rev Panam Salud Publica 2020; 44:e78.</a></li><li><a class="nounderline abstract_t">Kawaguchi L, Sengkeopraseuth B, Tsuyuoka R, et al. Seroprevalence of leptospirosis and risk factor analysis in flood-prone rural areas in Lao PDR. Am J Trop Med Hyg 2008; 78:957.</a></li><li><a class="nounderline abstract_t">Miyazato KE, Fonseca A, Caputto LZ, et al. Incidence of Leptospirosis infection in the East Zone of Sao Paulo City, Brazil. Int Arch Med 2013; 6:23.</a></li><li><a class="nounderline abstract_t">Dechet AM, Parsons M, Rambaran M, et al. Leptospirosis outbreak following severe flooding: a rapid assessment and mass prophylaxis campaign; Guyana, January-February 2005. PLoS One 2012; 7:e39672.</a></li><li><a class="nounderline abstract_t">Smith JK, Young MM, Wilson KL, Craig SB. Leptospirosis following a major flood in Central Queensland, Australia. Epidemiol Infect 2013; 141:585.</a></li><li><a class="nounderline abstract_t">Frawley AA, Schafer IJ, Galloway R, et al. Notes from the Field: Postflooding Leptospirosis - Louisiana, 2016. MMWR Morb Mortal Wkly Rep 2017; 66:1158.</a></li><li class="breakAll">World Health Organization. Leptospirosis - United Republic of Tanzania. https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON403#:~:text=Outbreak%20at%20a%20glance,cases%20have%20been%20laboratory%2Dconfirmed. (Accessed on August 21, 2022).</li><li><a class="nounderline abstract_t">Morgan J, Bornstein SL, Karpati AM, et al. Outbreak of leptospirosis among triathlon participants and community residents in Springfield, Illinois, 1998. Clin Infect Dis 2002; 34:1593.</a></li><li><a class="nounderline abstract_t">Stone SC, McNutt E. Update: Outbreak of acute febrile illness among athletes participating in Eco-Challenge-Sabah 2000--Borneo, Malaysia, 2000. Ann Emerg Med 2001; 38:83.</a></li><li><a class="nounderline abstract_t">Radl C, Müller M, Revilla-Fernandez S, et al. Outbreak of leptospirosis among triathlon participants in Langau, Austria, 2010. Wien Klin Wochenschr 2011; 123:751.</a></li><li><a class="nounderline abstract_t">Brockmann S, Piechotowski I, Bock-Hensley O, et al. Outbreak of leptospirosis among triathlon participants in Germany, 2006. BMC Infect Dis 2010; 10:91.</a></li><li><a class="nounderline abstract_t">Stern EJ, Galloway R, Shadomy SV, et al. Outbreak of leptospirosis among Adventure Race participants in Florida, 2005. Clin Infect Dis 2010; 50:843.</a></li><li class="breakAll">United States Centers for Disease Control and Prevention. Emergency Preparedness and Response. Advice to Clinicians about Leptospirosis in U.S. Travelers Returning from Northern Israel. https://emergency.cdc.gov/han/han00414.asp (Accessed on September 11, 2018).</li><li><a class="nounderline abstract_t">Pavli A, Maltezou HC. Travel-acquired leptospirosis. J Travel Med 2008; 15:447.</a></li><li><a class="nounderline abstract_t">Sohan L, Shyamal B, Kumar TS, et al. Studies on leptospirosis outbreaks in Peddamandem Mandal of Chittoor district, Andhra Pradesh. J Commun Dis 2008; 40:127.</a></li><li><a class="nounderline abstract_t">Katz AR, Ansdell VE, Effler PV, et al. Assessment of the clinical presentation and treatment of 353 cases of laboratory-confirmed leptospirosis in Hawaii, 1974-1998. Clin Infect Dis 2001; 33:1834.</a></li><li><a class="nounderline abstract_t">Vilaichone RK, Mahachai V, Wilde H. Acute acalculous cholecystitis in leptospirosis. J Clin Gastroenterol 1999; 29:280.</a></li><li><a class="nounderline abstract_t">Vanasco NB, Schmeling MF, Lottersberger J, et al. Clinical characteristics and risk factors of human leptospirosis in Argentina (1999-2005). Acta Trop 2008; 107:255.</a></li><li><a class="nounderline abstract_t">Puca E, Pilaca A, Kalo T, et al. Ocular and cutaneous manifestation of leptospirosis acquired in Albania: A retrospective analysis with implications for travel medicine. Travel Med Infect Dis 2016; 14:143.</a></li><li><a class="nounderline abstract_t">Sanford JP. Leptospirosis--time for a booster. N Engl J Med 1984; 310:524.</a></li><li><a class="nounderline abstract_t">Berman SJ, Tsai CC, Holmes K, et al. Sporadic anicteric leptospirosis in South Vietnam. A study in 150 patients. Ann Intern Med 1973; 79:167.</a></li><li><a class="nounderline abstract_t">Stefos A, Georgiadou SP, Gioti C, et al. Leptospirosis and pancytopenia: two case reports and review of the literature. J Infect 2005; 51:e277.</a></li><li><a class="nounderline abstract_t">Johnson WD Jr, Silva IC, Rocha H. Serum creatine phosphokinase in leptospirosis. JAMA 1975; 233:981.</a></li><li class="breakAll">Feigin RD, Lowry AW. Leptospirosis. In: Feigin and Cherry's Textbook of pediatric infectious diseases, 6th edition,  p.1810.</li><li><a class="nounderline abstract_t">Helmer RE 3rd, Millsaps RD. Letter: Hypoglycorrachia in leptospirosis. Ann Intern Med 1973; 79:912.</a></li><li><a class="nounderline abstract_t">Romero EC, Blanco RM, Yasuda PH. Aseptic meningitis caused by Leptospira spp diagnosed by polymerase chain reaction. Mem Inst Oswaldo Cruz 2010; 105:988.</a></li><li><a class="nounderline abstract_t">Rathinam SR, Rathnam S, Selvaraj S, et al. Uveitis associated with an epidemic outbreak of leptospirosis. Am J Ophthalmol 1997; 124:71.</a></li><li><a class="nounderline abstract_t">von Ranke FM, Zanetti G, Hochhegger B, Marchiori E. Infectious diseases causing diffuse alveolar hemorrhage in immunocompetent patients: a state-of-the-art review. Lung 2013; 191:9.</a></li><li><a class="nounderline abstract_t">Dupont H, Dupont-Perdrizet D, Perie JL, et al. Leptospirosis: prognostic factors associated with mortality. Clin Infect Dis 1997; 25:720.</a></li><li><a class="nounderline abstract_t">Cetin BD, Harmankaya O, Hasman H, et al. Acute renal failure: a common manifestation of leptospirosis. Ren Fail 2004; 26:655.</a></li><li><a class="nounderline abstract_t">Hurst FP, Neff RT, Katz AR, et al. Acute kidney injury requiring hemodialysis in patients with anicteric leptospirosis. Clin Nephrol 2009; 72:186.</a></li><li><a class="nounderline abstract_t">Helmerhorst HJ, van Tol EN, Tuinman PR, et al. Severe pulmonary manifestation of leptospirosis. Neth J Med 2012; 70:215.</a></li><li><a class="nounderline abstract_t">Wu MS, Yang CW, Pan MJ, et al. Reduced renal Na+-K+-Cl- co-transporter activity and inhibited NKCC2 mRNA expression by Leptospira shermani: from bed-side to bench. Nephrol Dial Transplant 2004; 19:2472.</a></li><li><a class="nounderline abstract_t">Krishnan A, Karnad DR, Medhekar TP. Paralysis due to renal potassium wasting: an unusual presentation of leptospirosis. Nephrol Dial Transplant 2003; 18:2454.</a></li><li><a class="nounderline abstract_t">Daher Ede F, Zanetta DM, Abdulkader RC. Pattern of renal function recovery after leptospirosis acute renal failure. Nephron Clin Pract 2004; 98:c8.</a></li><li><a class="nounderline abstract_t">Segura ER, Ganoza CA, Campos K, et al. Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden. Clin Infect Dis 2005; 40:343.</a></li><li><a class="nounderline abstract_t">Chierakul W, Tientadakul P, Suputtamongkol Y, et al. Activation of the coagulation cascade in patients with leptospirosis. Clin Infect Dis 2008; 46:254.</a></li><li><a class="nounderline abstract_t">Carvalho CR, Bethlem EP. Pulmonary complications of leptospirosis. Clin Chest Med 2002; 23:469.</a></li><li><a class="nounderline abstract_t">Assimakopoulos SF, Fligou F, Marangos M, et al. Anicteric leptospirosis-associated severe pulmonary hemorrhagic syndrome: a case series study. Am J Med Sci 2012; 344:326.</a></li><li><a class="nounderline abstract_t">Škerk V, Markotić A, Puljiz I, et al. Electrocardiographic changes in hospitalized patients with leptospirosis over a 10-year period. Med Sci Monit 2011; 17:CR369.</a></li><li><a class="nounderline abstract_t">Wong ML, Kaplan S, Dunkle LM, et al. Leptospirosis: a childhood disease. J Pediatr 1977; 90:532.</a></li><li><a class="nounderline abstract_t">Puliyath G, Singh S. Leptospirosis in pregnancy. Eur J Clin Microbiol Infect Dis 2012; 31:2491.</a></li><li><a class="nounderline abstract_t">Shaked Y, Shpilberg O, Samra D, Samra Y. Leptospirosis in pregnancy and its effect on the fetus: case report and review. Clin Infect Dis 1993; 17:241.</a></li><li><a class="nounderline abstract_t">Carles G, Montoya E, Joly F, Peneau C. [Leptospirosis and pregnancy. Eleven cases in French Guyana]. J Gynecol Obstet Biol Reprod (Paris) 1995; 24:418.</a></li><li><a class="nounderline abstract_t">Ganoza CA, Segura ER, Swancutt MA, et al. Mild, self-resolving acute leptospirosis in an HIV-infected patient in the Peruvian Amazon. Am J Trop Med Hyg 2005; 73:67.</a></li><li><a class="nounderline abstract_t">Neves Ede S, Pereira MM, Galhardo MC, et al. Leptospirosis patient with AIDS: the first case reported. Rev Soc Bras Med Trop 1994; 27:39.</a></li><li><a class="nounderline abstract_t">Jones S, Kim T. Fulminant leptospirosis in a patient with human immunodeficiency virus infection: case report and review of the literature. Clin Infect Dis 2001; 33:E31.</a></li><li><a class="nounderline abstract_t">Song AT, Abas L, Andrade LC, et al. A first report of leptospirosis after liver transplantation. Transpl Infect Dis 2016; 18:137.</a></li><li><a class="nounderline abstract_t">Philip N, Affendy NB, Masri SN, et al. Combined PCR and MAT improves the early diagnosis of the biphasic illness leptospirosis. PLoS One 2020; 15:e0239069.</a></li><li><a class="nounderline abstract_t">Iwasaki H, Chagan-Yasutan H, Leano PS, et al. Combined antibody and DNA detection for early diagnosis of leptospirosis after a disaster. Diagn Microbiol Infect Dis 2016; 84:287.</a></li><li><a class="nounderline abstract_t">Yang B, de Vries SG, Ahmed A, et al. Nucleic acid and antigen detection tests for leptospirosis. Cochrane Database Syst Rev 2019; 8:CD011871.</a></li><li><a class="nounderline abstract_t">Woods K, Nic-Fhogartaigh C, Arnold C, et al. A comparison of two molecular methods for diagnosing leptospirosis from three different sample types in patients presenting with fever in Laos. Clin Microbiol Infect 2018; 24:1017.e1.</a></li><li><a class="nounderline abstract_t">Pérez LJ, Lanka S, DeShambo VJ, et al. A Validated Multiplex Real-Time PCR Assay for the Diagnosis of Infectious Leptospira spp.: A Novel Assay for the Detection and Differentiation of Strains From Both Pathogenic Groups I and II. Front Microbiol 2020; 11:457.</a></li><li><a class="nounderline abstract_t">Limmathurotsakul D, Turner EL, Wuthiekanun V, et al. Fool's gold: Why imperfect reference tests are undermining the evaluation of novel diagnostics: a reevaluation of 5 diagnostic tests for leptospirosis. Clin Infect Dis 2012; 55:322.</a></li><li><a class="nounderline abstract_t">Picardeau M, Bertherat E, Jancloes M, et al. Rapid tests for diagnosis of leptospirosis: current tools and emerging technologies. Diagn Microbiol Infect Dis 2014; 78:1.</a></li><li><a class="nounderline abstract_t">Thaipadungpanit J, Chierakul W, Wuthiekanun V, et al. Diagnostic accuracy of real-time PCR assays targeting 16S rRNA and lipL32 genes for human leptospirosis in Thailand: a case-control study. PLoS One 2011; 6:e16236.</a></li><li><a class="nounderline abstract_t">Sonthayanon P, Chierakul W, Wuthiekanun V, et al. Accuracy of loop-mediated isothermal amplification for diagnosis of human leptospirosis in Thailand. Am J Trop Med Hyg 2011; 84:614.</a></li><li><a class="nounderline abstract_t">Koizumi N, Nakajima C, Harunari T, et al. A new loop-mediated isothermal amplification method for rapid, simple, and sensitive detection of Leptospira spp. in urine. J Clin Microbiol 2012; 50:2072.</a></li><li><a class="nounderline abstract_t">Cermakova Z, Kucerova P, Pliskova L, Kubickova P. Real-time PCR method for the detection of the gene encoding surface lipoprotein LipL32 of pathogenic Leptospira: use in the laboratory diagnosis of the acute form of leptospirosis. Scand J Infect Dis 2013; 45:593.</a></li><li><a class="nounderline abstract_t">Waggoner JJ, Pinsky BA. Molecular diagnostics for human leptospirosis. Curr Opin Infect Dis 2016; 29:440.</a></li><li><a class="nounderline abstract_t">Schreier S, Doungchawee G, Chadsuthi S, et al. Leptospirosis: current situation and trends of specific laboratory tests. Expert Rev Clin Immunol 2013; 9:263.</a></li><li><a class="nounderline abstract_t">Levett PN. Usefulness of serologic analysis as a predictor of the infecting serovar in patients with severe leptospirosis. Clin Infect Dis 2003; 36:447.</a></li><li><a class="nounderline abstract_t">Smythe LD, Wuthiekanun V, Chierakul W, et al. The microscopic agglutination test (MAT) is an unreliable predictor of infecting Leptospira serovar in Thailand. Am J Trop Med Hyg 2009; 81:695.</a></li><li><a class="nounderline abstract_t">Desakorn V, Wuthiekanun V, Thanachartwet V, et al. Accuracy of a commercial IgM ELISA for the diagnosis of human leptospirosis in Thailand. Am J Trop Med Hyg 2012; 86:524.</a></li><li><a class="nounderline abstract_t">Tanganuchitcharnchai A, Smythe L, Dohnt M, et al. Evaluation of the Standard Diagnostics Leptospira IgM ELISA for diagnosis of acute leptospirosis in Lao PDR. Trans R Soc Trop Med Hyg 2012; 106:563.</a></li><li><a class="nounderline abstract_t">Chen HW, Lukas H, Becker K, et al. An Improved Enzyme-Linked Immunoassay for the Detection of Leptospira-Specific Antibodies. Am J Trop Med Hyg 2018; 99:266.</a></li><li><a class="nounderline abstract_t">Jayasundara D, Gamage C, Senavirathna I, et al. Optimizing the microscopic agglutination test (MAT) panel for the diagnosis of Leptospirosis in a low resource, hyper-endemic setting with varied microgeographic variation in reactivity. PLoS Negl Trop Dis 2021; 15:e0009565.</a></li><li><a class="nounderline abstract_t">Levett PN, Whittington CU. Evaluation of the indirect hemagglutination assay for diagnosis of acute leptospirosis. J Clin Microbiol 1998; 36:11.</a></li><li><a class="nounderline abstract_t">Vedhagiri K, Velineni S, Timoney JF, et al. Detection of LipL32-specific IgM by ELISA in sera of patients with a clinical diagnosis of leptospirosis. Pathog Glob Health 2013; 107:130.</a></li><li><a class="nounderline abstract_t">Alia SN, Joseph N, Philip N, et al. Diagnostic accuracy of rapid diagnostic tests for the early detection of leptospirosis. J Infect Public Health 2019; 12:263.</a></li><li><a class="nounderline abstract_t">Hwee SE, Htet NH, Naing C, et al. Rapid diagnostic test (Leptocheck-WB) for detection of acute leptospirosis: a meta-analysis of diagnostic accuracy. Eur J Clin Microbiol Infect Dis 2022; 41:631.</a></li><li><a class="nounderline abstract_t">Girault D, Soupé-Gilbert ME, Geroult S, et al. Isolation of Leptospira from blood culture bottles. Diagn Microbiol Infect Dis 2017; 88:17.</a></li><li><a class="nounderline abstract_t">Wuthiekanun V, Amornchai P, Paris DH, et al. Rapid isolation and susceptibility testing of Leptospira spp. using a new solid medium, LVW agar. Antimicrob Agents Chemother 2013; 57:297.</a></li><li><a class="nounderline abstract_t">Gamage C, Sarathkumara Y, Weerakkodi V, et al. Development and evaluation of monoclonal antibody-based antigen capture enzyme-linked immunosorbent assay for the diagnosis of acute leptospirosis in humans. J Immunol Methods 2018; 463:134.</a></li><li><a class="nounderline abstract_t">Budihal SV, Perwez K. Leptospirosis diagnosis: competancy of various laboratory tests. J Clin Diagn Res 2014; 8:199.</a></li><li class="breakAll">Lambert H. Clinical approach to fever. In: Infectious diseases (Third edition) Volume 1. 2010; pg 679-687. Eds. Cohen J, Powderly W, Opal S. https://www.sciencedirect.com/topics/medicine-and-dentistry/conjunctival-suffusion (Accessed on August 21, 2022).</li><li><a class="nounderline abstract_t">Avšič-Županc T, Saksida A, Korva M. Hantavirus infections. Clin Microbiol Infect 2019; 21S:e6.</a></li><li class="breakAll">RMSF and serious tick-borne illnesses (Lyme, ehrlichiosis, babesiosis, and tick paralysis). Life-threatening rashes 2018; 215-240. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122147/ (Accessed on August 21, 2022).</li><li><a class="nounderline abstract_t">Karande S, Gandhi D, Kulkarni M, et al. Concurrent outbreak of leptospirosis and dengue in Mumbai, India, 2002. J Trop Pediatr 2005; 51:174.</a></li></ol></div><div id="topicVersionRevision">Topic 5527 Version 32.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31120895" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Revisiting the taxonomy and evolution of pathogenicity of the genus Leptospira through the prism of genomics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33620308" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Leptospira dzianensis and Leptospira putramalaysiae are later heterotypic synonyms of Leptospira yasudae and Leptospira stimsonii.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23359622" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : A single multilocus sequence typing (MLST) scheme for seven pathogenic Leptospira species.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15987533" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Development of a Multiple-Locus Variable Number of Tandem Repeat Analysis (MLVA) for Leptospira interrogans and its application to Leptospira interrogans serovar Australis isolates from Far North Queensland, Australia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12712204" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19756012" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26379143" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Global Morbidity and Mortality of Leptospirosis: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26431366" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Global Burden of Leptospirosis: Estimated in Terms of Disability Adjusted Life Years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26431366" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Global Burden of Leptospirosis: Estimated in Terms of Disability Adjusted Life Years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26431366" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Global Burden of Leptospirosis: Estimated in Terms of Disability Adjusted Life Years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26431366" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Global Burden of Leptospirosis: Estimated in Terms of Disability Adjusted Life Years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26431366" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Global Burden of Leptospirosis: Estimated in Terms of Disability Adjusted Life Years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15356794" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Risk factors for leptospirosis in metropolitan France: results of a national case-control study, 1999-2000.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15585507" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Percutaneous exposure resulting in laboratory-acquired leptospirosis -- a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23772568" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Leptospirosis--current risk factors connected with human activity and the environment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19700804" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Risk factors associated with leptospirosis during an outbreak in Middle Andaman, India.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23195639" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Cluster of leptospirosis cases among military personnel in Rio de Janeiro, Brazil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23295874" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Cases distribution of leptospirosis in City of Manaus, State of Amazonas, Brazil, 2000-2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33788864" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Poverty, sanitation, and Leptospira transmission pathways in residents from four Brazilian slums.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18431445" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Impact of environment and social gradient on Leptospira infection in urban slums.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32684917" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : A systematic literature review of leptospirosis outbreaks worldwide, 1970-2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18541776" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Seroprevalence of leptospirosis and risk factor analysis in flood-prone rural areas in Lao PDR.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23672682" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Incidence of Leptospirosis infection in the East Zone of Sao Paulo City, Brazil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22808049" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Leptospirosis outbreak following severe flooding: a rapid assessment and mass prophylaxis campaign; Guyana, January-February 2005.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22625176" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Leptospirosis following a major flood in Central Queensland, Australia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29073122" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Notes from the Field: Postflooding Leptospirosis - Louisiana, 2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29073122" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Notes from the Field: Postflooding Leptospirosis - Louisiana, 2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12032894" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Outbreak of leptospirosis among triathlon participants and community residents in Springfield, Illinois, 1998.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11423818" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Update: Outbreak of acute febrile illness among athletes participating in Eco-Challenge-Sabah 2000--Borneo, Malaysia, 2000.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22105111" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Outbreak of leptospirosis among triathlon participants in Langau, Austria, 2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20380736" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Outbreak of leptospirosis among triathlon participants in Germany, 2006.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20146629" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Outbreak of leptospirosis among Adventure Race participants in Florida, 2005.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20146629" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Outbreak of leptospirosis among Adventure Race participants in Florida, 2005.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19090801" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Travel-acquired leptospirosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19301697" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Studies on leptospirosis outbreaks in Peddamandem Mandal of Chittoor district, Andhra Pradesh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11692294" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Assessment of the clinical presentation and treatment of 353 cases of laboratory-confirmed leptospirosis in Hawaii, 1974-1998.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10509958" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Acute acalculous cholecystitis in leptospirosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18671932" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Clinical characteristics and risk factors of human leptospirosis in Argentina (1999-2005).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26732289" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Ocular and cutaneous manifestation of leptospirosis acquired in Albania: A retrospective analysis with implications for travel medicine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6694697" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Leptospirosis--time for a booster.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4726531" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Sporadic anicteric leptospirosis in South Vietnam. A study in 150 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15896845" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Leptospirosis and pancytopenia: two case reports and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1173921" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Serum creatine phosphokinase in leptospirosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1173921" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Serum creatine phosphokinase in leptospirosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4761927" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Letter: Hypoglycorrachia in leptospirosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21225195" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Aseptic meningitis caused by Leptospira spp diagnosed by polymerase chain reaction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9222235" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Uveitis associated with an epidemic outbreak of leptospirosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23128913" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Infectious diseases causing diffuse alveolar hemorrhage in immunocompetent patients: a state-of-the-art review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9314467" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Leptospirosis: prognostic factors associated with mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15600257" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Acute renal failure: a common manifestation of leptospirosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19761723" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Acute kidney injury requiring hemodialysis in patients with anicteric leptospirosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22744922" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Severe pulmonary manifestation of leptospirosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15388818" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Reduced renal Na+-K+-Cl- co-transporter activity and inhibited NKCC2 mRNA expression by Leptospira shermani: from bed-side to bench.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14551392" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Paralysis due to renal potassium wasting: an unusual presentation of leptospirosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15361699" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Pattern of renal function recovery after leptospirosis acute renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15668855" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18171258" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Activation of the coagulation cascade in patients with leptospirosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12092040" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Pulmonary complications of leptospirosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22739564" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Anicteric leptospirosis-associated severe pulmonary hemorrhagic syndrome: a case series study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21709630" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Electrocardiographic changes in hospitalized patients with leptospirosis over a 10-year period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/557083" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Leptospirosis: a childhood disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22549729" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Leptospirosis in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8399874" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Leptospirosis in pregnancy and its effect on the fetus: case report and review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7650320" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : [Leptospirosis and pregnancy. Eleven cases in French Guyana].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16014835" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Mild, self-resolving acute leptospirosis in an HIV-infected patient in the Peruvian Amazon.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8008919" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Leptospirosis patient with AIDS: the first case reported.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11477534" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Fulminant leptospirosis in a patient with human immunodeficiency virus infection: case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26671230" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : A first report of leptospirosis after liver transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32915919" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Combined PCR and MAT improves the early diagnosis of the biphasic illness leptospirosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26860351" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Combined antibody and DNA detection for early diagnosis of leptospirosis after a disaster.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31425612" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Nucleic acid and antigen detection tests for leptospirosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29092789" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : A comparison of two molecular methods for diagnosing leptospirosis from three different sample types in patients presenting with fever in Laos.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32265882" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : A Validated Multiplex Real-Time PCR Assay for the Diagnosis of Infectious Leptospira spp.: A Novel Assay for the Detection and Differentiation of Strains From Both Pathogenic Groups I and II.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22523263" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Fool's gold: Why imperfect reference tests are undermining the evaluation of novel diagnostics: a reevaluation of 5 diagnostic tests for leptospirosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24207075" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Rapid tests for diagnosis of leptospirosis: current tools and emerging technologies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21283633" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Diagnostic accuracy of real-time PCR assays targeting 16S rRNA and lipL32 genes for human leptospirosis in Thailand: a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21460019" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Accuracy of loop-mediated isothermal amplification for diagnosis of human leptospirosis in Thailand.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22422858" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : A new loop-mediated isothermal amplification method for rapid, simple, and sensitive detection of Leptospira spp. in urine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23848450" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Real-time PCR method for the detection of the gene encoding surface lipoprotein LipL32 of pathogenic Leptospira: use in the laboratory diagnosis of the acute form of leptospirosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27537829" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Molecular diagnostics for human leptospirosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23445200" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Leptospirosis: current situation and trends of specific laboratory tests.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12567302" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Usefulness of serologic analysis as a predictor of the infecting serovar in patients with severe leptospirosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19815889" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : The microscopic agglutination test (MAT) is an unreliable predictor of infecting Leptospira serovar in Thailand.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22403329" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Accuracy of a commercial IgM ELISA for the diagnosis of human leptospirosis in Thailand.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22818757" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Evaluation of the Standard Diagnostics Leptospira IgM ELISA for diagnosis of acute leptospirosis in Lao PDR.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29943710" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : An Improved Enzyme-Linked Immunoassay for the Detection of Leptospira-Specific Antibodies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34197457" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Optimizing the microscopic agglutination test (MAT) panel for the diagnosis of Leptospirosis in a low resource, hyper-endemic setting with varied microgeographic variation in reactivity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9431911" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Evaluation of the indirect hemagglutination assay for diagnosis of acute leptospirosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23683367" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Detection of LipL32-specific IgM by ELISA in sera of patients with a clinical diagnosis of leptospirosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30502041" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Diagnostic accuracy of rapid diagnostic tests for the early detection of leptospirosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35147814" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Rapid diagnostic test (Leptocheck-WB) for detection of acute leptospirosis: a meta-analysis of diagnostic accuracy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28189283" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Isolation of Leptospira from blood culture bottles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23114772" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Rapid isolation and susceptibility testing of Leptospira spp. using a new solid medium, LVW agar.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30217719" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Development and evaluation of monoclonal antibody-based antigen capture enzyme-linked immunosorbent assay for the diagnosis of acute leptospirosis in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24596774" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Leptospirosis diagnosis: competancy of various laboratory tests.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24596774" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Leptospirosis diagnosis: competancy of various laboratory tests.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24750436" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Hantavirus infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24750436" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Hantavirus infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15831670" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Concurrent outbreak of leptospirosis and dengue in Mumbai, India, 2002.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
